$0.32
3.15% yesterday
Nasdaq, Jun 11, 10:02 pm CET
ISIN
US09075X1081
Symbol
BDSX

Biodesix Inc Stock price

$0.32
-0.04 11.07% 1M
-0.98 75.42% 6M
-1.21 79.11% YTD
-1.23 79.38% 1Y
-12.49 97.51% 5Y
-12.49 97.51% 10Y
-12.49 97.51% 20Y
Nasdaq, Closing price Wed, Jun 11 2025
-0.01 3.15%
ISIN
US09075X1081
Symbol
BDSX
Sector

Key metrics

Market capitalization $46.84m
Enterprise Value $65.95m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.89
P/S ratio (TTM) P/S ratio 0.63
P/B ratio (TTM) P/B ratio 4.23
Revenue growth (TTM) Revenue growth 35.75%
Revenue (TTM) Revenue $74.46m
EBIT (operating result TTM) EBIT $-32.37m
Free Cash Flow (TTM) Free Cash Flow $-45.24m
Cash position $17.60m
EPS (TTM) EPS $-0.29
P/E forward negative
P/S forward 0.57
EV/Sales forward 0.81
Short interest 3.33%
Show more

Is Biodesix Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.

Biodesix Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Biodesix Inc forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Biodesix Inc forecast:

Buy
83%
Hold
17%

Financial data from Biodesix Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
74 74
36% 36%
100%
- Direct Costs 16 16
24% 24%
22%
58 58
40% 40%
78%
- Selling and Administrative Expenses 80 80
17% 17%
108%
- Research and Development Expense 10 10
18% 18%
14%
-27 -27
17% 17%
-36%
- Depreciation and Amortization 5.79 5.79
46% 46%
8%
EBIT (Operating Income) EBIT -32 -32
10% 10%
-43%
Net Profit -40 -40
14% 14%
-54%

In millions USD.

Don't miss a Thing! We will send you all news about Biodesix Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biodesix Inc Stock News

Neutral
GlobeNewsWire
2 days ago
Nation's first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programs Nation's first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programs
Neutral
GlobeNewsWire
21 days ago
LOUISVILLE, Colo., May 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that new data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois at 2:30 pm ET on Saturday, May 31st.
Neutral
GlobeNewsWire
22 days ago
LOUISVILLE, Colo., May 21, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that members of the Biodesix management team, will participate in two upcoming investor conferences:
More Biodesix Inc News

Company Profile

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It is a data-driven diagnostic solutions company with proprietary AI platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The firm offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. . The company was founded in 2005 and is headquartered in Boulder, CO.

Head office United States
CEO Scott Hutton
Employees 217
Founded 2005
Website www.biodesix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today